Financial Post EN

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a […]

Mar 09, 2026 &03030909202631; 13:03 UTC financialpost.com Trending 4/5

Read original on financialpost.com ↗

↗

Positive for markets

Sentiment score: +75/100

Moderate impact Medium-term (weeks)

WHAT THIS MEANS

Medidata, a Dassault Systèmes subsidiary, has expanded its partnership with The Menarini Group to deploy AI-powered Study Build technology for accelerating oncology clinical trials. This 14-year collaboration evolution combines established clinical workflows with artificial intelligence to enhance Menarini's global oncology pipeline development.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

DASTY

DASTYStock

Expected to rise

Dassault Systèmes subsidiary Medidata secures expanded partnership demonstrating strong demand for AI-powered clinical trial solutions

↑

Euro Stoxx 50

^STOXX50EIndex

Expected to rise

European healthcare and technology sector benefits from innovation in clinical trial acceleration

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Monitor Dassault Systèmes for continued expansion of Medidata's AI capabilities in life sciences. This partnership validates the market demand for AI-driven clinical trial solutions, suggesting positive revenue trajectory for the subsidiary and potential upside for parent company stock.

KEY SIGNALS

AI technology adoption in pharmaceutical R&D acceleratingLong-term partnership expansion indicates customer confidenceOncology pipeline focus reflects high-value therapeutic areaDigital transformation in clinical trials gaining momentum

SECTORS INVOLVED

Healthcare & PharmaceuticalsSoftware & TechnologyClinical Research & Development

Analysis generated on Mar 09, 2026 at 13:18 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Financial Post. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

RELATED INTELLIGENCE